Barbara Kantorová

Recurrent mutations refine prognosis in chronic lymphocytic leukemia

Panagiotis Baliakas, Anastasia Hadzidimitriou, L-A Sutton et al. · Leukemia · 2014 · 278 citations · Full text

Medicine, Molecular Genetics, Oncology +14

Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia

Jitka Malčíková, Kateřina Staňo Kozubík, Boris Tichý et al. · Leukemia · 2014 · 145 citations · Full text

Medicine, Molecular Biology, Oncology +17

Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 mutational status

Blanka Kubešová, Šárka Pavlová, Jitka Malčíková et al. · Leukemia · 2017 · 76 citations · Full text

Medicine, Hematology, Oncology +15

Decreased <i><scp>WNT</scp>3</i> expression in chronic lymphocytic leukaemia is a hallmark of disease progression and identifies patients with worse prognosis in the subgroup with mutated <i><scp>IGHV</scp></i>

Lucie Poppová, Pavlína Janovská, Karla Plevová et al. · British Journal of Haematology · 2016 · 13 citations · Full text

Medicine, Cancer Biology, Oncology +16

TP53 mutation analysis in chronic lymphocytic leukemia: comparison of different detection methods

Barbara Kantorová, Jitka Malčíková, Jana Šmardová et al. · Tumor Biology · 2014 · 12 citations

Medicine, Genetics, Hematology +17